Prognostic analysis of patients with combined hepatocellular-cholangiocarcinoma after radical resection: A retrospective multicenter cohort study

doi:10.3748/wjg.v28.i41.5968

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 28, Issue 41

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5193)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-2) series.

Item

Count

PDF

216

WORD

HTML

2536

Figures (1-5)

369

Tables (1-2)

333

Sum=3522

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

203

Download

593

Sum=796

Publishing Process of This Article

Item

Count

Browse

169

Download

706

Sum=875

Nov 7, 2022 (publication date) through Nov 4, 2024

Times Cited of This Article

Times Cited (8)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Nov 7, 2022; 28(41): 5968-5981
Published online Nov 7, 2022. doi: 10.3748/wjg.v28.i41.5968

Full Size Figure Download Figure

Figure 5 Nomogram for overall survival and recurrence-free survival. A: Overall survival (OS) nomogram for patients with combined hepatocellular-cholangiocarcinoma (cHCC-CCA); B: Calibration curve of overall survival for 1- and 2-year OS; C: Recurrence-free survival (RFS) nomogram for patients with cHCC-CCA; D: Calibration curve of recurrence-free survival for 3-mo and 6-mo RFS. OS: Overall survival; RFS: Recurrence-free survival; TBR: Treatment before recurrence; AFP: Alpha-fetoprotein.

Citation: Zhang G, Chen BW, Yang XB, Wang HY, Yang X, Xie FC, Chen XQ, Yu LX, Shi J, Lu YY, Zhao HT. Prognostic analysis of patients with combined hepatocellular-cholangiocarcinoma after radical resection: A retrospective multicenter cohort study. World J Gastroenterol 2022; 28(41): 5968-5981
URL: https://www.wjgnet.com/1007-9327/full/v28/i41/5968.htm
DOI: https://dx.doi.org/10.3748/wjg.v28.i41.5968